Therefore, tumor regions have abundant lymphocyte infiltration and elevated programmed death-ligand 1 (PD-L1) expression, making immunotherapy a promising option for the treatment of NPC (7, 8). Here, CD274 is linked to nasopharyngeal carcinoma.